Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does FLUOROURACIL Cause Neoplasm progression? 903 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 903 reports of Neoplasm progression have been filed in association with FLUOROURACIL (FLUOROURACIL). This represents 1.7% of all adverse event reports for FLUOROURACIL.

903
Reports of Neoplasm progression with FLUOROURACIL
1.7%
of all FLUOROURACIL reports
228
Deaths
163
Hospitalizations

How Dangerous Is Neoplasm progression From FLUOROURACIL?

Of the 903 reports, 228 (25.2%) resulted in death, 163 (18.1%) required hospitalization, and 34 (3.8%) were considered life-threatening.

Is Neoplasm progression Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for FLUOROURACIL. However, 903 reports have been filed with the FAERS database.

What Other Side Effects Does FLUOROURACIL Cause?

Diarrhoea (5,373) Neutropenia (4,400) Nausea (3,757) Vomiting (2,836) Off label use (2,788) Neuropathy peripheral (2,605) Thrombocytopenia (2,426) Fatigue (2,421) Disease progression (2,377) Febrile neutropenia (2,230)

What Other Drugs Cause Neoplasm progression?

PALBOCICLIB (10,885) SUNITINIB MALATE (1,920) CYCLOPHOSPHAMIDE (1,588) CARBOPLATIN (1,370) AXITINIB (1,315) DOXORUBICIN (1,276) LETROZOLE (1,225) PACLITAXEL (1,180) CRIZOTINIB (1,161) VINCRISTINE (1,106)

Which FLUOROURACIL Alternatives Have Lower Neoplasm progression Risk?

FLUOROURACIL vs FLUOROURACIL\IRINOTECAN\LEUCOVORIN FLUOROURACIL vs FLUOROURACIL\IRINOTECAN\LEUCOVORIN\OXALIPLATIN FLUOROURACIL vs FLUOROURACIL\LEUCOVORIN\OXALIPLATIN FLUOROURACIL vs FLUOXETINE FLUOROURACIL vs FLUOXETINE\FLUOXETINE

Related Pages

FLUOROURACIL Full Profile All Neoplasm progression Reports All Drugs Causing Neoplasm progression FLUOROURACIL Demographics